SABS · Categories · Form 4

SABS - SEC Form 4 insider transactions

SAB Biotherapeutics Inc. (SABS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SABS

• 70d
  SEC Form 4 filed by Kropotova Alexandra

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 118d
  SEC Form 4 filed by PRESIDENT Sullivan Eddie Joe

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 118d
  SEC Form 4 filed by CEO Reich Samuel J

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 118d
  SEC Form 4 filed by CHIEF OPERATING OFFICER Bausch Christoph Lawrence

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 118d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Kropotova Alexandra

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 118d
  SEC Form 4 filed by Officer To Lucy

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 147d
  SEC Form 4 filed by Director Jain Rita

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 147d
  SEC Form 4 filed by Director Zaccardelli David

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 167d
  SEC Form 4 filed by Director Skyler Jay S

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 167d
  SEC Form 4 filed by Director Polvino William James

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 167d
  SEC Form 4 filed by Director Lucera Erick

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 167d
  SEC Form 4 filed by Director Ellias Helen K.

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 167d
  SEC Form 4 filed by Director Giberson Scott

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 167d
  SEC Form 4 filed by Director Link David

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 173d
  CHIEF MEDICAL OFFICER Kropotova Alexandra covered exercise/tax liability with 988 shares, decreasing direct ownership by 2% to 44,284 units (SEC Form 4)

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 245d
  Director Moin Andrew exercised 1,740,000 shares at a strike of $1.75 (SEC Form 4)

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 245d
  Director Sessa Capital (Master), L.P. exercised 1,740,000 shares at a strike of $1.75 (SEC Form 4)

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 254d
  CHIEF MEDICAL OFFICER Kropotova Alexandra covered exercise/tax liability with 1,977 shares, decreasing direct ownership by 4% to 45,272 units (SEC Form 4)

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 279d
  SEC Form 4 filed by CEO & EXECUTIVE CHAIRMAN Reich Samuel J

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 279d
  SEC Form 4 filed by Officer To Lucy

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 279d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Kropotova Alexandra

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 279d
  SEC Form 4 filed by CHIEF OPERATING OFFICER Bausch Christoph Lawrence

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 279d
  SEC Form 4 filed by PRESIDENT Sullivan Eddie Joe

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 314d
  SEC Form 4 filed by Director Sessa Capital (Master), L.P.

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 314d
  SEC Form 4 filed by Director Moin Andrew

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 428d
  CHIEF MEDICAL OFFICER Kropotova Alexandra covered exercise/tax liability with 1,179 shares, decreasing direct ownership by 2% to 47,249 units (SEC Form 4)

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 519d
  CHIEF MEDICAL OFFICER Kropotova Alexandra covered exercise/tax liability with 9,072 shares, decreasing direct ownership by 16% to 48,428 units (SEC Form 4)

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 575d
  SEC Form 4 filed by Director Ellias Helen K.

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 659d
  SEC Form 4 filed by Officer To Lucy

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 686d
  SEC Form 4 filed by Director Spragens Jeffrey G

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 686d
  SEC Form 4 filed by Director Polvino William James

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 686d
  SEC Form 4 filed by CEO & EXECUTIVE CHAIRMAN Reich Samuel J

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 686d
  SEC Form 4 filed by Director Skyler Jay S

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 686d
  SEC Form 4 filed by Director Link David Charles

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 686d
  SEC Form 4 filed by Director Giberson Scott

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 686d
  SEC Form 4 filed by PRESIDENT Sullivan Eddie Joe

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 686d
  SEC Form 4 filed by Director Lucera Erick

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 686d
  SEC Form 4 filed by Director Hamilton Christine E

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 831d
  SEC Form 4 filed by Kropotova Alexandra

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 831d
  SEC Form 4 filed by Bausch Christoph Lawrence

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 831d
  SEC Form 4 filed by Sullivan Eddie Joe

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 831d
  SEC Form 4 filed by King Michael

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 831d
  SEC Form 4 filed by Reich Samuel J

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 918d
  Sessa Capital (Master), L.P. converted options into 4,584,571 shares (SEC Form 4)

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 918d
  Moin Andrew converted options into 4,584,571 shares (SEC Form 4)

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 918d
  Ellias Helen K. converted options into 2,857,142 shares (SEC Form 4)

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 931d
  SEC Form 4 filed by Moin Andrew (Amendment)

  4/A - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 931d
  SEC Form 4 filed by Sessa Capital (Master), L.P. (Amendment)

  4/A - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 932d
  SEC Form 4 filed by Moin Andrew

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 943d
  SEC Form 4 filed by King Michael

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 953d
  SEC Form 4 filed by Sessa Capital (Master), L.P.

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 953d
  SEC Form 4 filed by Moin Andrew

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 1155d
  SEC Form 4 filed by Lucera Erick

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 1175d
  SEC Form 4: Kropotova Alexandra was granted 275,000 shares

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 1175d
  SEC Form 4 filed by Sullivan Eddie Joe

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 1175d
  SEC Form 4 filed by Reich Samuel J

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 1175d
  SEC Form 4 filed by Bausch Christoph Lawrence

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 1175d
  SEC Form 4 filed by Beyer Russell P

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 1190d
  SEC Form 4 filed by Spragens Jeffrey G

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)
• 1190d
  SEC Form 4 filed by Reich Samuel J

  4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)

Other SABS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends